Apple has begun enrolling up to 200,000 U.S. adults in the Apple Health AI Usage Study, a research program conducted with clinical AI platform OpenEvidence to examine how people use, understand and evaluate AI-generated medical information. The study will run for more than 12 months.
Launched on Nov. 15, the program aims to help participants better understand health concerns and prepare for consultations with doctors.
Participation in the study is open to U.S. residents aged 21 and older who own an iPhone 15 Pro or newer model running iOS 26 or later. Enrolled participants can use a dedicated app to submit medical questions and receive answers in accessible language, accompanied by links to peer-reviewed scientific research.
READ: Apple TV adds sign language interpretation to select original titles (November 10, 2026)
Participants will also complete monthly surveys. The system draws on medical literature from prominent publications, including The New England Journal of Medicine, the Journal of the American Medical Association and Nature.
“At Apple, we believe responsible innovation starts with scientific rigor and clinical grounding. Health is deeply personal, and conducting a dedicated research study is the most thoughtful way to understand how people engage with, comprehend, and evaluate health AI in everyday life,” said Sumbul Desai, M.D., Apple’s vice president of Health and Fitness.
The iPhone maker is also giving participants the option to connect their HealthKit records to the app. These records can include physical activity, sleep, resting heart rate and laboratory results, allowing responses to incorporate personal health context. Apple says the tool may help users prepare questions for medical appointments and identify healthcare providers when a query raises a potentially concerning issue.
“Patients and clinicians are both turning to AI, but the tools they use are being built and tested in separate worlds,” said Robert M. Wachter, M.D., professor and chair of the Department of Medicine at the University of California, San Francisco. “When patients and doctors draw on versions of the same trustworthy tools, patients arrive prepared, conversations improve, and next steps happen seamlessly. Connecting these tools, and rigorously studying what works, is how we’ll get there.”
Privacy is another central aspect of the initiative. Apple says information will be anonymized before being transferred to a secure third-party cloud provider and will not be used to train AI models. According to the company, participants retain control over whether to share HealthKit metrics or survey responses, while OpenEvidence will delete users’ queries and responses after 24 hours.
The app operates separately from Apple Intelligence and Siri within a dedicated research environment. Apple has not clarified whether the technology could eventually become part of its Health app or voice assistant.
READ: New Apple CEO John Ternus to overhaul leadership team as senior executives near retirement (August 31, 2026)
OpenEvidence is a Miami-based company founded in 2022 by Daniel Nadler, who holds a PhD from Harvard University, and Zachary Ziegler, according to the company’s background information. The platform has supported more than 200 million clinical consultations and is widely used by verified U.S. health care professionals. The company says its platform is developed in partnership with leading medical journals and organizations, including the NEJM Group and the JAMA Network.
“OpenEvidence is the most trusted and loved brand product among doctors. Apple is the most trusted and loved brand and product among consumers, and especially health consumers. So you have to bring these two things together. It’s like peanut butter and jelly,” OpenEvidence CEO Daniel Nadler wrote on X.


